US Stock MarketDetailed Quotes
CRMD CorMedix
- 9.860
- -0.120-1.20%
Close Nov 29 13:00 ET
- 9.860
- 0.0000.00%
Post 17:01 ET
598.28MMarket Cap-12325P/E (TTM)
10.170High9.750Low323.40KVolume9.980Open9.980Pre Close3.20MTurnover0.54%Turnover RatioLossP/E (Static)60.68MShares13.85052wk High10.19P/B592.65MFloat Cap2.89052wk Low--Dividend TTM60.11MShs Float52.000Historical High--Div YieldTTM4.21%Amplitude0.729Historical Low9.888Avg Price1Lot Size
About CorMedix Company
CorMedix, Inc. is a pharmaceutical and medical device company, which engages in the development and commercialization of therapeutic products for the prevention and treatment of diseases and conditions. The company was founded by Antony E. Pfaffle on July 28, 2006 and is headquartered in Berkeley Heights, NJ.
Company Profile
SymbolCRMD
Company NameCorMedix
Listing DateMay 13, 2010
Founded2006
CEOMr. Joseph Todisco
MarketNASDAQ
Employees83
Fiscal Year Ends12-31
Address300 Connell Drive,Suite 4200
CityBerkeley Heights
ProvinceNew Jersey
CountryUnited States of America
Zip Code07922
Phone1-908-517-9500
Websitehttp://www.cormedix.com
Company Executives
- Name
- Position
- Salary
- Joseph Todisco
- Director and Chief Executive Officer
- 2.46M
- Dr. Matthew T. David, M.D.
- Executive Vice President, Chief Financial Officer and Principal Accounting Officer
- --
- Beth Zelnick Kaufman
- Executive Vice President and Chief Legal Officer and Corporate Secretary
- --
- Erin Mistry
- Executive Vice President and Chief Commercial Officer
- 1.24M
- Elizabeth Hurlburt
- Executive Vice President and Chief Clinical Strategy and Operations Officer
- --
- Myron Kaplan
- Chairman of the Board
- 191.96K
- Gregory Duncan
- Independent Director
- 141.42K
- Dr. Alan W. Dunton,M.D.
- Independent Director
- 141.42K
- Steven W. Lefkowitz
- Independent Director
- 162.42K
- Robert A. Stewart
- Independent Director
- 202.58K
- Janet M. Dillione
- Independent Director
- 147.42K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data